Application 103353
- Type
- BLA
- Sponsor
- AMGEN
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 103353 | Neupogen | filgrastim | 351(a) | Rx | 2026-10-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NEUPOGEN | FILGRASTIM | VIAL | 300MCG/1ML | No | No |
| 002 | NEUPOGEN | FILGRASTIM | VIAL | 480MCG/1.6ML | No | No |
| 003 | NEUPOGEN | FILGRASTIM | SYRINGE | 300MGC/0.5ML | No | No |
| 004 | NEUPOGEN | FILGRASTIM | SYRINGE | 480MCG/0.8ML | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
NDC listings for this application page 1 of 1 ยท 28 matching rows.
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 55513-209 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-209 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-209 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-209 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-209 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-209 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-209 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-530 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-530 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-530 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-530 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-530 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-530 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-530 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-546 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-546 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-546 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-546 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-546 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-546 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-546 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-924 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-924 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-924 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-924 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-924 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-924 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |
| 55513-924 | NEUPOGEN | Filgrastim | Amgen Inc | BLA | Current |